Skip to main content
PTGX $158.59 +2.25%
PTGX logo

PTGX · Protagonist Therapeutics, Inc

Track PTGX — free
$158.59 +3.49 (+2.25%)
Market Cap
$10.04B
Shares
64.71M
All earnings calls

Earnings call · FY2024 Q4

Protagonist Therapeutics, Inc Q4 FY2024 Earnings Call

Protagonist Therapeutics, Inc Q4 FY2024 Earnings Call

Concluded Feb 21, 2025
Feb 21, 2025 0 turns
Period
FY2024 Q4
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $170.64M +184.4% YoY
Net income · derived Q4 $131.67M +381.7% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document